Global Local Anesthesia Drugs Market to Reach $4.3 Billion by 2030

Jun 19, 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, July 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Local Anesthesia Drugs Industry" - https://www.reportlinker.com/p06032076/?utm_source=GNW Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.Global Local Anesthesia Drugs Market to Reach $4.3 Billion by 2030In the changed post COVID-19 business landscape, the global market for Local Anesthesia Drugs estimated at US$2.9 Billion in the year 2022, is projected to reach a revised size of US$4.3 Billion by 2030, growing at aCAGR of 5.1% over the period 2022-2030. Lidocaine, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Bupivacaine segment is readjusted to a revised 6.8% CAGR for the next 8-year period.The U.S. Market is Estimated at $781.7 Million, While China is Forecast to Grow at 8.9% CAGRThe Local Anesthesia Drugs market in the U.S. is estimated at US$781.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$955.1 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.Select Competitors (Total 43 Featured)- Aspen Pharmacare- Fresenius SE & Co. KGaA- Mylan- Pacira Pharmaceuticals, Inc.- Pfizer Inc.- Pierrel group- Sagent Pharmaceutical, Inc.- Teva PharmaceuticalsRead the full report: https://www.reportlinker.com/p06032076/?utm_source=GNW I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEWInfluencer Market InsightsWorld Market TrajectoriesImpact of Covid-19 and a Looming Global RecessionLocal Anesthesia Drugs - Global Key Competitors PercentageMarket Share in 2022 (E)Competitive Market Presence - Strong/Active/Niche/Trivial forPlayers Worldwide in 2022 (E)2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVETable 1: World Recent Past, Current & Future Analysis for LocalAnesthesia Drugs by Geographic Region - USA, Canada, Japan,China, Europe, Asia-Pacific, Latin America, Middle East andAfrica Markets - Independent Analysis of Annual Sales in US$Million for Years 2022 through 2030 and % CAGRTable 2: World Historic Review for Local Anesthesia Drugs byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 3: World 16-Year Perspective for Local Anesthesia Drugsby Geographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa Markets for Years 2014, 2023 & 2030Table 4: World Recent Past, Current & Future Analysis forLidocaine by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific, Latin America, Middle East and AfricaMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2022 through 2030 and % CAGRTable 5: World Historic Review for Lidocaine by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Million for Years 2014 through 2021 and% CAGRTable 6: World 16-Year Perspective for Lidocaine by GeographicRegion - Percentage Breakdown of Value Sales for USA, Canada,Japan, China, Europe, Asia-Pacific, Latin America, Middle Eastand Africa for Years 2014, 2023 & 2030Table 7: World Recent Past, Current & Future Analysis forBupivacaine by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific, Latin America, Middle East and AfricaMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2022 through 2030 and % CAGRTable 8: World Historic Review for Bupivacaine by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Million for Years 2014 through 2021 and% CAGRTable 9: World 16-Year Perspective for Bupivacaine byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2014, 2023 & 2030Table 10: World Recent Past, Current & Future Analysis forRopivacaine by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific, Latin America, Middle East and AfricaMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2022 through 2030 and % CAGRTable 11: World Historic Review for Ropivacaine by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Million for Years 2014 through 2021 and% CAGRTable 12: World 16-Year Perspective for Ropivacaine byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2014, 2023 & 2030Table 13: World Recent Past, Current & Future Analysis forPrilocaine by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific, Latin America, Middle East and AfricaMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2022 through 2030 and % CAGRTable 14: World Historic Review for Prilocaine by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Million for Years 2014 through 2021 and% CAGRTable 15: World 16-Year Perspective for Prilocaine byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2014, 2023 & 2030Table 16: World Recent Past, Current & Future Analysis forOther Product Segments by Geographic Region - USA, Canada,Japan, China, Europe, Asia-Pacific, Latin America, Middle Eastand Africa Markets - Independent Analysis of Annual Sales inUS$ Million for Years 2022 through 2030 and % CAGRTable 17: World Historic Review for Other Product Segments byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 18: World 16-Year Perspective for Other Product Segmentsby Geographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2014, 2023 & 2030Table 19: World Recent Past, Current & Future Analysis forInjectable by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific, Latin America, Middle East and AfricaMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2022 through 2030 and % CAGRTable 20: World Historic Review for Injectable by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Million for Years 2014 through 2021 and% CAGRTable 21: World 16-Year Perspective for Injectable byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2014, 2023 & 2030Table 22: World Recent Past, Current & Future Analysis forSurface Anesthetic by Geographic Region - USA, Canada, Japan,China, Europe, Asia-Pacific, Latin America, Middle East andAfrica Markets - Independent Analysis of Annual Sales in US$Million for Years 2022 through 2030 and % CAGRTable 23: World Historic Review for Surface Anesthetic byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 24: World 16-Year Perspective for Surface Anesthetic byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2014, 2023 & 2030Table 25: World Local Anesthesia Drugs Market Analysis ofAnnual Sales in US$ Million for Years 2014 through 2030III. MARKET ANALYSISUNITED STATESLocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)Table 26: USA Recent Past, Current & Future Analysis for LocalAnesthesia Drugs by Product Segment - Lidocaine, Bupivacaine,Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 27: USA Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 28: USA 16-Year Perspective for Local Anesthesia Drugs byProduct Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 29: USA Recent Past, Current & Future Analysis for LocalAnesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 30: USA Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 31: USA 16-Year Perspective for Local Anesthesia Drugs byApplication - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030CANADATable 32: Canada Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 33: Canada Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 34: Canada 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 35: Canada Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 36: Canada Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 37: Canada 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030JAPANLocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)Table 38: Japan Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 39: Japan Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 40: Japan 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 41: Japan Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 42: Japan Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 43: Japan 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030CHINALocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)Table 44: China Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 45: China Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 46: China 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 47: China Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 48: China Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 49: China 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030EUROPELocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)Table 50: Europe Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Geographic Region - France, Germany,Italy, UK, Spain, Russia and Rest of Europe Markets -Independent Analysis of Annual Sales in US$ Million for Years2022 through 2030 and % CAGRTable 51: Europe Historic Review for Local Anesthesia Drugs byGeographic Region - France, Germany, Italy, UK, Spain, Russiaand Rest of Europe Markets - Independent Analysis of AnnualSales in US$ Million for Years 2014 through 2021 and % CAGRTable 52: Europe 16-Year Perspective for Local Anesthesia Drugsby Geographic Region - Percentage Breakdown of Value Sales forFrance, Germany, Italy, UK, Spain, Russia and Rest of EuropeMarkets for Years 2014, 2023 & 2030Table 53: Europe Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 54: Europe Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 55: Europe 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 56: Europe Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 57: Europe Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 58: Europe 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030FRANCELocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)Table 59: France Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 60: France Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 61: France 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 62: France Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 63: France Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 64: France 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030GERMANYLocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)Table 65: Germany Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 66: Germany Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 67: Germany 16-Year Perspective for Local AnesthesiaDrugs by Product Segment - Percentage Breakdown of Value Salesfor Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 68: Germany Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 69: Germany Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 70: Germany 16-Year Perspective for Local AnesthesiaDrugs by Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030ITALYTable 71: Italy Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 72: Italy Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 73: Italy 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 74: Italy Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 75: Italy Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 76: Italy 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030UNITED KINGDOMLocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)Table 77: UK Recent Past, Current & Future Analysis for LocalAnesthesia Drugs by Product Segment - Lidocaine, Bupivacaine,Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 78: UK Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 79: UK 16-Year Perspective for Local Anesthesia Drugs byProduct Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 80: UK Recent Past, Current & Future Analysis for LocalAnesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 81: UK Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 82: UK 16-Year Perspective for Local Anesthesia Drugs byApplication - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030SPAINTable 83: Spain Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 84: Spain Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 85: Spain 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 86: Spain Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 87: Spain Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 88: Spain 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030RUSSIATable 89: Russia Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 90: Russia Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 91: Russia 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 92: Russia Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 93: Russia Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 94: Russia 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030REST OF EUROPETable 95: Rest of Europe Recent Past, Current & Future Analysisfor Local Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 96: Rest of Europe Historic Review for Local AnesthesiaDrugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 97: Rest of Europe 16-Year Perspective for LocalAnesthesia Drugs by Product Segment - Percentage Breakdown ofValue Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaineand Other Product Segments for the Years 2014, 2023 & 2030Table 98: Rest of Europe Recent Past, Current & Future Analysisfor Local Anesthesia Drugs by Application - Injectable andSurface Anesthetic - Independent Analysis of Annual Sales inUS$ Million for the Years 2022 through 2030 and % CAGRTable 99: Rest of Europe Historic Review for Local AnesthesiaDrugs by Application - Injectable and Surface AnestheticMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2014 through 2021 and % CAGRTable 100: Rest of Europe 16-Year Perspective for LocalAnesthesia Drugs by Application - Percentage Breakdown of ValueSales for Injectable and Surface Anesthetic for the Years 2014,2023 & 2030ASIA-PACIFICLocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)Table 101: Asia-Pacific Recent Past, Current & Future Analysisfor Local Anesthesia Drugs by Geographic Region - Australia,India, South Korea and Rest of Asia-Pacific Markets -Independent Analysis of Annual Sales in US$ Million for Years2022 through 2030 and % CAGRTable 102: Asia-Pacific Historic Review for Local AnesthesiaDrugs by Geographic Region - Australia, India, South Korea andRest of Asia-Pacific Markets - Independent Analysis of AnnualSales in US$ Million for Years 2014 through 2021 and % CAGRTable 103: Asia-Pacific 16-Year Perspective for LocalAnesthesia Drugs by Geographic Region - Percentage Breakdown ofValue Sales for Australia, India, South Korea and Rest ofAsia-Pacific Markets for Years 2014, 2023 & 2030Table 104: Asia-Pacific Recent Past, Current & Future Analysisfor Local Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 105: Asia-Pacific Historic Review for Local AnesthesiaDrugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 106: Asia-Pacific 16-Year Perspective for LocalAnesthesia Drugs by Product Segment - Percentage Breakdown ofValue Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaineand Other Product Segments for the Years 2014, 2023 & 2030Table 107: Asia-Pacific Recent Past, Current & Future Analysisfor Local Anesthesia Drugs by Application - Injectable andSurface Anesthetic - Independent Analysis of Annual Sales inUS$ Million for the Years 2022 through 2030 and % CAGRTable 108: Asia-Pacific Historic Review for Local AnesthesiaDrugs by Application - Injectable and Surface AnestheticMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2014 through 2021 and % CAGRTable 109: Asia-Pacific 16-Year Perspective for LocalAnesthesia Drugs by Application - Percentage Breakdown of ValueSales for Injectable and Surface Anesthetic for the Years 2014,2023 & 2030AUSTRALIALocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)Table 110: Australia Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 111: Australia Historic Review for Local Anesthesia Drugsby Product Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 112: Australia 16-Year Perspective for Local AnesthesiaDrugs by Product Segment - Percentage Breakdown of Value Salesfor Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 113: Australia Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 114: Australia Historic Review for Local Anesthesia Drugsby Application - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 115: Australia 16-Year Perspective for Local AnesthesiaDrugs by Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030INDIALocal Anesthesia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)Table 116: India Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 117: India Historic Review for Local Anesthesia Drugs byProduct Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 118: India 16-Year Perspective for Local Anesthesia Drugsby Product Segment - Percentage Breakdown of Value Sales forLidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 119: India Recent Past, Current & Future Analysis forLocal Anesthesia Drugs by Application - Injectable and SurfaceAnesthetic - Independent Analysis of Annual Sales in US$Million for the Years 2022 through 2030 and % CAGRTable 120: India Historic Review for Local Anesthesia Drugs byApplication - Injectable and Surface Anesthetic Markets -Independent Analysis of Annual Sales in US$ Million for Years2014 through 2021 and % CAGRTable 121: India 16-Year Perspective for Local Anesthesia Drugsby Application - Percentage Breakdown of Value Sales forInjectable and Surface Anesthetic for the Years 2014, 2023 &2030SOUTH KOREATable 122: South Korea Recent Past, Current & Future Analysisfor Local Anesthesia Drugs by Product Segment - Lidocaine,Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -Independent Analysis of Annual Sales in US$ Million for theYears 2022 through 2030 and % CAGRTable 123: South Korea Historic Review for Local AnesthesiaDrugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine,Prilocaine and Other Product Segments Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2014 through2021 and % CAGRTable 124: South Korea 16-Year Perspective for Local AnesthesiaDrugs by Product Segment - Percentage Breakdown of Value Salesfor Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and OtherProduct Segments for the Years 2014, 2023 & 2030Table 125: South Korea Recent Past, Current & Future Analysisfor Local Anesthesia Drugs by Application - Injectable andPlease contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06032076/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________